Blood is one of the body’s most vital organs, yet it remains one of the most overlooked in health policy. Through its Blood Health Initiative, the Global Alliance
This week the FDA approved a new oral PCSK9 inhibitor, the first in that class available as a once-daily pill rather than an injection, for adults with hypercholesterolemia.